The Oncology Institute Q1 EPS $(0.22) Misses $(0.12) Estimate, Sales $94.67M Miss $95.16M Estimate
The Oncology Institute Q1 EPS $(0.22) Misses $(0.12) Estimate, Sales $94.67M Miss $95.16M Estimate
肿瘤学研究所第一季度每股收益（0.22）未达到预期（0.12）美元，销售额为9,467万美元，低于预期的9,516万美元
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 33.33 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $94.67 million which missed the analyst consensus estimate of $95.16 million by 0.52 percent. This is a 24.25 percent increase over sales of $76.19 million the same period last year.
肿瘤学研究所（纳斯达克股票代码：TOI）公布的季度亏损为每股0.22美元，比分析师共识估计的0.12美元（0.12美元）低83.33％。与去年同期每股亏损0.33美元（0.33美元）相比，增长了33.33％。该公司公布的季度销售额为9,467万美元，比分析师普遍预期的9,516万美元低0.52％。这比去年同期的7,619万美元销售额增长了24.25％。